AnaptysBio Awarded U.S. Government Contract To Develop Anti-Ricin Antibodies PR Newswire (press release) SAN DIEGO, May 16, 2013 /PRNewswire/ -- AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced the receipt of a contract award from the U.S. government for the development of highly thermostable anti-ricin antibodies for ... |
